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Abstract: Background: Investigations in factor VII activating protease (FSAP)-/- mice suggest a role for FSAP in stroke, 
thrombosis and neointima formation. Here, we analyzed the role of FSAP in vascular remodeling processes related 
to arteriogenesis and angiogenesis in the mouse hind limb ischemia model. Methods and results: Femoral artery 
ligation was performed in mice and exogenous FSAP was injected locally to examine its effect on arteriogenesis in 
the adductor and angiogenesis in the gastrocnemius muscle over 21 days. Perfusion was decreased by FSAP, which 
was reflected in a lower arterial diameter and was associated with reduced monocyte infiltration in the adductor 
muscle. There was increased angiogenesis in the gastrocnemius muscle triggered indirectly by less blood supply to 
the lower limb. Comparison of wild-type (WT) and FSAP-/- mice showed that perfusion was not different between the 
genotypes but there were 2.5-fold more collateral arteries in the adductor muscle of FSAP-/- mice at day 21. This was 
associated with a higher infiltration of monocytes at day 3. Capillary density in the gastrocnemius muscle was not 
altered. Activity of the two major proteolytic pathways associated with vascular remodeling; matrix metalloprotease 
(MMP)-9 and urokinase-type plasminogen activator (uPA) was elevated in the gastrocnemius but not in the adductor 
muscle in FSAP-/- mice. Conclusions: Arteriogenesis is enhanced, and this is associated with a higher infiltration of 
monocytes, in the absence of endogenous FSAP but angiogenesis is unchanged. Exogenous FSAP had the opposite 
effect on arteriogenesis indicating a possible therapeutic potential of modulating endogenous FSAP.
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Introduction
In vascular occlusive diseases new vessels 
form either via capillary sprouting, termed 
angiogenesis, or via remodeling of pre-existing 
arteriolar connections into collateral arteries, 
a process named arteriogenesis. Tissue isch-
emia can lead to spontaneous angiogenesis 
and arteriogenesis to overcome the local 
loss of perfusion. When an artery develops a 
hemodynamically relevant stenosis, circulating 
mononuclear blood cells are attracted and 
migrate into the vessel wall, giving rise to the 
production of multiple cytokines and growth 
factors [1]. This local inflammatory reaction 
results in proliferation and growth of the 
collateral vasculature through a complex in- 
terplay between endothelial cells, vascular 
smooth muscle cells (VSMC) and monocytes 
[2]. Mediators that are involved in this process 
include chemokine (C-C motif) ligand-2 (CCL-2), 
vascular endothelial growth factor (VEGF), basic 
fibroblast growth factor (FGF-2), and platelet 
derived growth factor (PDGF)-AB are shown to 
be up-regulated in arteriogenesis and drive the 
large expansion in SMC [3]. 
Factor VII activating protease (FSAP) is encoded 
by a gene named hyaluronic acid binding pro-
tein 2 (HABP2). FSAP is a circulating plasma 
serine protease with multifunctional proper- 
ties [4]. Genetic epidemiological studies have 
shown that the G534E single nucleotide poly-
morphism (SNP) in the FSAP gene, also called 
the Marburg I (MI) polymorphism (rs7080536), 
is found in about 5% of Caucasians and is 
associated with late complications of carotid 
stenosis [5] and stroke [6]. MI-FSAP has about 
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a 5-fold lower proteolytic activity towards all 
substrates tested and thus represents a loss-
of-function polymorphism [7]. We have previ-
ously shown that the local application of exog-
enous wild type (WT)-FSAP but not MI-FSAP 
following wire-induced injury of the femoral 
artery was able to inhibit neointimal lesion for-
mation and SMC proliferation [8] whereas 
FSAP-/- mice showed enhanced neointima 
formation [9]. These data indicate that the 
cellular regulatory effects of FSAP could be 
important in the context of vascular remo- 
deling processes. FSAP was also shown to 
reduce endothelial cell permeability via pro-
tease activated receptors (PARs) [10]. 
There are two reports to date that demonstrat-
ed that FSAP inhibits neovascularisation. In 
the chicken chorioallantoic membrane model 
recombinant FSAP was shown to be anti-angio-
genic and it was proposed that the kringle 
domain was responsible, since a FSAP mutant 
without the kringle domain was not effective 
[11]. However, no evidence was provided that 
the mutant was correctly folded or if it had any 
enzymatic activity. Another report indicated 
that FGF-2-mediated endothelial cell prolifera-
tion is inhibited by FSAP due to binding, se- 
questering and/or degradation of the growth 
factor. This inhibition of cell proliferation was 
dependent on the proteolytic activity of FSAP 
[12]. The same authors also demonstrated 
that FSAP releases FGF-2 and bradykinin from 
endothelial cells [13]. 
Considering that MI-SNP is associated with a 
higher risk of vascular diseases as well as the 
known effects of FSAP on vascular remodeling 
processes we hypothesized that FSAP influenc-
es the responses to hind limb ischemia. After 
ligation of the femoral artery in FSAP-/- mice, 
collateral arterial growth was increased that 
was associated with enhanced monocyte accu-
mulation. This was further supported by oppo-
site effects of exogenously applied FSAP indi-
cating that FSAP is a novel factor in vascular 
remodeling process in vivo.
Methods
FSAP-/- mice
FSAP-/- mice (official name: B6129S5-Hab- 
p2tm1Lex) were generated as recently described 
[14] and were backcrossed with C57BL/6J 
mice for 2 generations and heterozygous cross-
es were set up to produce FSAP-/- mice and lit-
termate controls. Sex and age matched litter-
mates were compared in all experiments and 
all animals were maintained in the same room 
under SPF conditions. All procedures involving 
experimental animals were approved by the 
local government animal care committee and 
complied with the Guide for the Care and Use of 
Laboratory Animals (NIH publication No. 86-23, 
revised 1985). 
Mouse femoral artery ligation model
10-12 weeks old mice were anaesthetized 
with 100 mg body weight ketamine hydrochlo-
ride (Ketanest®, Pfizer, Berlin, Germany) and 
2 mg body weight xylazine hydrochloride 
(Rompun®, Bayer, Leverkusen, Germany). The 
femoral artery was occluded by a double liga-
tion with 6-0 silk sutures (Ethicon, Norderstedt, 
Germany) distal to the origin of the deep 
femoral artery and proximal to the origin of 
any other distal branch [15]. 
FSAP isolation and intra-muscular application
FSAP was isolated as described previously [16]. 
The buffer for FSAP was diluted in 0.2 M argi-
nine, 0.2 M lysine, 5 mM citrate, pH 4.5 and 
this buffer was also used at the appropriate 
dilution to exclude any influence of the vehicle 
in all experiments. 7.5 μg of FSAP was injected 
into the upper hind limb at 5 defined points in a 
final volume of 30 ul in C57BL6/J mice at 1 h, 
24 h and 3 days after the femoral artery 
ligation.
Laser Doppler perfusion imaging (LDPI)
Laser Doppler perfusion imaging was used to 
record serial blood flow measurements before 
and after the ligation of the left femoral artery 
and furthermore over a period of 3 weeks, post-
operatively. The animals were placed for 5 min 
on a 38°C heating plate (Föhr Instruments, 
Seeheim-Ober, Germany) to avoid vasocon-
striction by anaesthetic heat loss. The LDPI 
system (PeriScan System, Perimed, Järfälla, 
Sweden) scans the skin of the mouse foot up 
to a depth of 500 µm and the mean signal 
intensity is represented by false colours. For 
calculation of the hind limb perfusion the mean 
pixel intensity of both legs was determined and 
a “perfusion index” (ligated/unligated side) was 
used for quantification [17, 18].
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dimensional reconstruction was performed 
using Imaris 7.2 the multichannel image pro-
cessing software (Bitplane, Zurich, Switzerland).
Preparation of tissue extracts
Tissue pieces were homogenized in a glass 
homogenizer in TBS (50 mM Tris, pH 7.4, 
containing 100 mM NaCl) with 1% (w/v) SDS. 
After centrifugation the extracts were frozen at 
-80°C until further analysis. 
qPCR
RNA was extracted using Total RNA Miniprep 
Kit (Sigma Aldrich). Reverse transcription was 
performed using High Capacity cDNA Reverse 
Transcription Kit (Applied Biosystems). For 
real-time PCR, SensiMix SYBR Kit (Bioline, 
Luckenwalde, Germany) was used and analysis 
was performed on a Step One Plus Real-Time 
PCR System (Applied Biosystems). Melting 
curve was performed at 60°C for 1 min follow-
ing 95°C for 15 sec. Amplification plot was 
monitored over 40 cycles and continuous 
fluorescence measurement indicated mRNA 
expression of analyzed genes. Fluorescent 
threshold cycles (ct) were set and normalized 
against ct of housekeeping gene GAPDH (Δct). 
Afterwards expression of target gene was cal-
culated as 2-Δct.
Quantitative zymography and western blotting
Tissue extracts were boiled for Western blot-
ting but not for zymography. After normal SDS-
PAGE the gels were washed with Triton X-100 
(1%) and overlayed with an agarose gel contain-
ing casein and plasminogen. Dark bands indi-
cated proteolysis of casein and the activation 
of plasminogen. For gelatine zymography 0.2% 
(w/v) was directly incorporated into the gel and 
after extensive washing was incubated for 48 h 
at 37°C. Coomassie staining identified gelatin-
ase activity as clear bands. Western blot with 
anti-COX IV was performed to adjust for differ-
ences in protein concentrations. Band density 
was measured using the image analysis 
system Quantity One system (Biorad, Munich, 
Germany).
FSAP levels in plasma
These were measured as described previously 
[20].
Immune histochemistry and morphometrical 
analysis
1, 3 and 7 days after ligation, tissue samples of 
adductor and gastrocnemius muscle from both 
hind limb muscles were snap-frozen in methyl 
butane and stored at -80°C until use [19]. 
Cryosections of 5-7 µm thickness were pre-
pared with a Leica CM 1900 Cryomicrotome 
(Leica, Wetzlar, Germany), fixed and permeabi-
lized in ice cold acetone, blocked with serum 
free protein block (Dako, Hamburg, Germany) 
for 20 minutes and incubation with rabbit anti-
CD31 (Abcam, Cambridge, UK) for 1 h at room 
temperature, followed by appropriate cross-
absorbed secondary antibody conjugated to 
Cy3 fluorochrome (Jackson ImmunoResearch 
Suffolk, UK). An FITC-conjugated mouse anti 
mouse-SMC-α-actin antibody (Sigma Aldrich, 
Hamburg, Germany) was included as a counter-
stain, followed by nuclear counterstain with 
DAPI. Only vessels with media-to-lumen-ratio 
typical for arteries were counted and their dia-
meter determined. Sections were analyzed on 
an AxioverS100 (Carl Zeiss, Jena, Germany) 
equipped with appropriate filters sets and a 
RT/SE camera system (Diagnostic Instru- 
ments, Sterling Heights, MI USA). A total of 10 
sections per animal were stained and vessel 
density was quantified by a single blind ob- 
server, the SpotAdvanced system/ImagePro 
(Media Cybernetics Inc., Bethesda, MD USA) 
and furthermore the computer Imaging System 
(MetaMorph™, Molecular Devices Sunnyvale, 
U.S.A.). 
For confocal microscopy, cryosections of 10 
µm were fixed in 4% (wt/vol) paraformaldehyde 
and incubated with a rat antibody raised 
against the mouse CD68 antigen (Serotec, 
Puchheim, Germany). It was followed by bioti-
nylated secondary donkey anti-rat antiserum 
(Dianova, Hamburg, Germany) and Cy2-
Streptavidin (Rockland, USA). After repeated 
washes in PBS, sections were incubated with 
anti-SMC-α-actin directly labeled with Cy3 
(Sigma). F-actin was visualized with phalloidin 
conjugated with Alexa 633 (Molecular Probes). 
Finally, nuclei were stained with DAPI. The sec-
tions were examined by laser scanning confo-
cal microscopy LEICA TCS5 which allows 4 
channel concomitant scanning. Ten confocal 
optical sections were taken through the depth 
of tissue samples at 0.5 μm intervals by using 
a Leica Planapo 63/1.4 objective. Three-
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Statistics
Statistical analysis was carried out using SAS® 
software, version 9.2 (SAS Institute Inc., Cary, 
NC, USA) and SPSS 22 (IBM, Germany). To ana-
lyze these effects we performed a two factorial 
ANOVA with cross effects using the GLM proce-
dure in SAS®. In case of a significant global test 
the Tukey test was used as post hoc test for 
pairwise group comparisons. Significance lev-
els were associated with the adjusted F-Test 
by Huynh-Feldt. P-values are used to differ 
between the significance levels factors in 
ANOVA. All statistical decisions were made 
two-tailed with a critical probability of a=5% 
without a-adjustment except the Tukey test for 
pairwise group comparisons. For all biochemi-
cal data one way ANOVA followed by Bonferroni 
post hoc test was used. A p value of <0.05 was 
considered to be significant.
Results
Effect of exogenous FSAP on arteriogenesis 
and angiogenesis
After femoral artery ligation, the effect of direct 
local application of FSAP protein and control 
buffer on blood flow, collateral vascular growth 
in adductor muscle (upper leg) and angiogene-
Figure 1. Perfusion in mice after application of exogenous FSAP. A. After femoral artery ligation in WT mice, the 
recovery of perfusion over 21 days was determined in FSAP-treated mice compared to buffer treatment using LPDI. 
The contralateral limb was used as an internal control for calculating left to right ratios to correct for inter-individual 
differences. Mean ± SD (n=8, *P<0.05). The 2-factor ANOVA for treatment groups (FSAP and buffer) as the main 
factor and the restoration of hind limb perfusion from the time point post-ligation up to 21 days as the repeated fac-
tor shows significance between these 2 factors and in cross effects of these factors at day 1, 3, 7 and 14 (P<0.05). 
Tukey’s post hoc test at day 1, 3, 7 and 14 indicates a difference between buffer and FSAP (P<0.05). Only the sig-
nificant differences between the two treatment groups are indicated by *. B. Representative LPDI images of mice 
from each group are shown. 
FSAP regulates vascular remodeling
3088 Am J Transl Res 2017;9(6):3084-3095
sis in gastrocnemius (lower leg) was deter-
mined over 21 days. Perfusion index was mea-
sured by laser Doppler perfusion imaging (LDPI) 
and calculated as mean pixel intensity of ligat-
ed/un-ligated side. Application of FSAP led to a 
delay in the recovery of perfusion index at day 
1, 3, 7 and 14 after ligation but perfusion 
reached a plateau at day 21 and was identical 
thereafter (Figure 1). This was confirmed histo-
logically since FSAP-treated animals showed a 
post ligation, histological evaluation demon-
strated more collateral arteries with a larger 
vessel diameter in the upper limb of FSAP-/- 
mice (P<0.05) (Figure 3C, 3D). In contrast, cap-
illary density in the gastrocnemius muscle did 
not show any significant differences between 
the genotypes (Figure 3E). Collateral growth 
and angiogenesis is dependent on the accumu-
lation of monocytes/macrophages, so we also 
determined the number of monocytes/macro-
Figure 2. Arteriogenesis in mice after application of exogenous FSAP. After 
femoral artery ligation histological analysis of collateral arteries in adductor 
and gastrocnemius muscle sections of the ischemic hind limb at 21 days 
was performed. Staining of αSMC, CD31, F4/80 and nuclei was used to 
identify collateral arteries in the adductor muscle (A) (ANOVA, mean ves-
sel diameter ± SD, n=6, *P<0.05, Tukey’s post hoc test). Capillary density 
in the gastrocnemius muscle (ANOVA, number/μm2 ± SD, n=6, *P<0.05 
(day 7, 14 and 21, Tukey’s post hoc test) (B) and infiltrating macrophages 
(C) in both muscles (ANOVA, cell/collateral vessel, means ± SD, n=6, 
*P<0.05, Tukey’s post hoc test, significant only within the adductor muscle). 
Only the significant differences between the two treatment groups are indi-
cated by *.
lesser increase of the vessel 
diameter compared to control 
buffer treated animals 7 days 
after ligation (P<0.05). How- 
ever, there were no subse-
quent differences at later time 
points (Figure 2A). Capillary 
density in the adductor mus-
culature, determined by the 
CD31 positive signals per 
defined area, showed no sig-
nificant differences between 
the FSAP and control group 
(data not shown), while the 
capillary density in the gas-
trocnemius muscle was in- 
creased 2-fold (P<0.05) in 
the FSAP group (Figure 2B). 
Application of exogenous 
FSAP reduced the number of 
monocytes in the adductor 
muscle, but this was not the 
case in the gastrocnemius 
muscle (Figure 2C). Thus, 
application of exogenous FS- 
AP inhibited arteriogenesis in 
the upper limb and this result-
ed in a reflex increase in angio-
genesis in the lower limb due 
to sustained hypoxia.
Effect of FSAP deficiency on 
arteriogenesis and angiogen-
esis
After ligation of the femoral 
artery in FSAP-/- mice and lit-
termate WT mice, remodeling 
in the hind limbs was deter-
mined. The drop in perfusion 
and the subsequent recovery 
after 7, 14 and 21 days were 
similar in both genotypes 
(Figure 3A, 3B). At 21 days 
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phages cells at time points 1, 3 and 7 days 
after ligation (Figure 4). Quantitative analysis 
showed that the number of monocytes/macro-
phages was statistically higher in FSAP-/- mice 
compared to WT mice at day 3 (P<0.05) but 
not on day 1 or day 7 (Figure 5A). The number 
gastrocnemius of FSAP-/- mice at the activity 
and protein level (Figure 6). 
Since it has been reported that FSAP can 
activate pro-urokinase (uPA) we also measured 
the mRNA levels of uPA in tissue undergoing 
Figure 3. Vascular remodeling in the hind limb after femoral artery ligation 
in WT and FSAP-/- mice. A. Perfusion was measured using LPDI over 21 days 
as indicated in the figure. The unligated/contralateral limb was used as an 
internal control for calculating left to right ratios to correct for inter-individual 
differences. Between these groups, no significant differences were noted 
(The results are presented as mean ± SD., n=8, *P<0.05 ANOVA. ANOVA 
indicates analysis of variance. And Tukey’s post hoc test. B. Representative 
LPDI images of mice from each group are shown. C. Histological analysis 
of collateral arteries in the adductor muscle sections of the ischemic hind 
limb at 21 days. Staining of αSMC and nuclei was used to identify collateral 
arteries (ANOVA, collateral arteries/muscle ± SD, n=6, *P<0.05, Tukey’s 
post hoc test). D. Diameter of the identified arteries (μm) was determined 
morphometrically (ANOVA, meanvessel diameter ± SD, Tukey’s post hoc test 
not significant, n=6). E. Histological analysis of angiogenesis in the gastroc-
nemius muscle sections of the ischemic hind limb at 21 days. Staining of 
CD31 and nuclei was used to identify capillaries (ANOVA, number/μm2 ± SD, 
n=6, Tukey’s post hoc test). Only the significant differences between the two 
genotypes are indicated by *.
of cells was very low in the 
unligated limbs and not differ-
ent between the genotypes. 
Circulating FSAP levels were 
not altered at 1, 3 and 7 days 
after ligation in WT mice and 
no FSAP was detected in 
FSAP-/- mice (Figure 5B). The 
lack of endogenous FSAP led 
to an increase in arteriogene-
sis in the upper limb as deter-
mined histologically but re- 
covery of perfusion was unaf-
fected. This was associated 
with an increase in the num-
ber of monocytes. Angioge- 
nesis in the lower limb was 
not affected by the lack of 
endogenous FSAP.
Levels of MMP-2, MMP-9 and 
uPA during remodeling in 
FSAP-/- mice
Since FSAP is a circulating 
protease, we hypothesized 
that difference in remodeling 
between the genotypes are 
related to an altered proteo-
lytic balance. We quantified 
gelatinase activity in tissue 
extracts at day 3 in relation to 
the expression of the house 
keeping enzyme cytochrome 
oxidase IV. In the adductor 
muscle there was no induc-
tion of either MMP-2 or 
MMP-9 mRNA, protein levels 
or activity after ligation in 
both strains of mice (Figure 
6). In the gastrocnemius mus-
cle there was a tendency 
towards increased MMP-2 
and MMP-9 mRNA but this 
was not significantly diffe- 
rent between both genotypes. 
MMP-9 was increased in the 
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Figure 4. Accumula-
tion of monocytes in 
arteriogenesis. Adduc-
tor muscle from WT 
and FSAP-/- mice days 
1, 3 and 7 after femo-
ral artery ligation were 




cle, red), α-smooth 
muscle actin (VSMC, 
grey) and nuclei (DAPI, 
blue) as indicated in 
the figure.
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vascular remodeling. Adductor muscles showed 
no significant changes in uPA (Figure 7). 
Increased uPA mRNA, protein and activity was 
observed in the gastrocnemius muscle of 
FSAP-/- mice (Figure 7). Thus, angiogenesis in 
the gastrocnemius muscle, but not collateral 
formation in the adductor muscle, was associ-
ated with differences in the proteolytic path-
ways between the two genotypes.
Discussion
FSAP-/- mice display no obvious developmental 
defects and the histology of the adult liver, 
lungs and heart showed no abnormalities, indi-
cating that endogenous FSAP has no major role 
in vascular remodeling processes during devel-
opment. However, when adult FSAP-/- mice were 
subjected to femoral artery ligation, which 
leads to hind limb ischemia and vascular 
remodeling in the limb, the lack of endogenous 
FSAP caused distinct changes in the remodel-
ing process. Increased arteriogenesis in the 
adductor muscle could be measured in terms 
of an increase in the number of arteries as 
well as their diameter in FSAP-/- mice. This 
increased arteriogenesis in FSAP-/- mice com-
pared with WT mice was not measurable using 
the LPDI method probably because this meth-
od is not sensitive enough to determine small 
changes or that the changes are in the deeper 
tissue levels that are not readily quantified by 
LPDI [21]. Upon exogenous FSAP application, 
we observed a significantly delayed increase in 
vessel diameter associated with a slower recov-
ery of hind limb perfusion as measured by 
LPDI. The difference in LPDI results between 
mice that lack endogenous FSAP and exoge-
nous FSAP application would suggest that the 
latter has a more robust effect on arteriogene-
sis. These data provide comparable results to 
those obtained in the injury induced neointima 
formation; application of exogenous FSAP inhib-
ited this process [8] whereas it was enhanced 
in FSAP-/- mice [9]. Both these results confirm a 
role for FSAP in vascular remodeling in vivo in 
adult mice. Contrary to the mechanism of 
collateral vessel growth, in which fluid shear 
stress is one of the most potent triggers; angio-
genesis is mostly triggered by ischemia. After 
ligation of the femoral artery, ischemia typically 
occurs in the lower hind limb (gastrocnemius) 
leading to sprout capillary growth [22]. There 
was no significant difference in angiogenesis 
between the two strains of mice. However, cap-
illary density was increased in mice with exog-
enous FSAP application. We conclude that 
local intramuscular administration of FSAP in 
the upper limb resulted in a delay of arteriogen-
esis after ligation of the femoral artery in mice. 
This resulted in an increase of ischemia in the 
calf region and induces angiogenesis in this 
area. Thus, at least in vivo a lack of endoge-
nous FSAP does not seem to have any direct 
consequences for angiogenesis which refutes 
earlier reports obtained using in vitro methods 
[11-13]. One of the key drivers of vascular 
remodeling processes is monocytes/macro-
phages and we found evidence for increased 
number of macrophages as sites of arteriogen-
Figure 5. Quantitative analysis of monocytes in arteriogenesis and circulating FSAP levels. A. Adductor muscle from 
WT and FSAP-/- mice 1, 3 and 7 days after femoral artery ligation were stained for CD68 as described in legend to 
Figure 4 and quantified (means ± SEM, n=5, *P<0.05, ANOVA followed by Bonferroni post test. B. Plasma FSAP 
activity was measured using a combination of immune capture and activity assay. No FSAP was detected in the 
plasma of FSAP-/- mice. Values were quantified with human plasma as a standard reference (mU/ml ± SEM, n=5, 
*P<0.05, ANOVA followed by Bonferroni post test). Only the significant differences between the two genotypes are 
indicated by *.
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esis at the initial stages of remodeling. We 
have previously reported that there were no 
generalized changes in the number of 
leukocytes in the circulation of FSAP-/- mice 
[9]. The difference in monocyte accumulation 
between WT and FSAP-/- mice was only tran-
sient at day 3 but this may be sufficient to 
consequence of alterations in their expression, 
activation of the zymogen forms as well as the 
relative concentration of their inhibitors we 
have measured these at the mRNA, protein and 
activity level. In the adductor muscle there were 
no significant changes in the mRNA, protein lev-
els activity as for MMP-2, MMP-9 or uPA 
Figure 6. Expression of MMP-2 and MMP-9 in arteriogenesis. In the excised 
gastrocnemius and adductor muscles of WT- and FSAP-/- mice MMP-2, MMP-
9 mRNA (A, D), activity (B, E) and protein (C, F) were measured 3 days after 
injury using qPCR; protease activity was related to the expression of cyto-
chrome C Oxidase (COXIV) as measured by Western blotting. Antigen levels 
were also measured by Western blotting. Densitometry was performed to 
quantify activity and antigen levels (ANOVA followed by Bonferroni post test, 
means ± SEM, n=4, *P<0.05); only the significant differences between the 
two genotypes are indicated by *.
account for the increased 
number of arteries measured. 
The enhanced leukocyte acc- 
umulation complements our 
observations in the mouse 
stroke [23] model, neointimal 
lesion formation [9] as well as 
the liver fibrosis [14] model 
that we have investigated in 
these mice. An increased sen-
sitivity of FSAP-/- leukocytes to 
chemokine CCL-2 in the cre-
master vessels using intravi-
tal microscopy underscores 
this repeated observation 
across various model sys-
tems. It is likely that the 
increased inflammatory res- 
ponse also induces an 
enhanced secretion of vari-
ous growth factors, which in 
turn exaggerate proliferation 
of smooth muscle cells and 
endothelial cells [24]. 
Vascular remodeling is asso- 
ciated with changes in the 
expression pattern of matrix 
components, their degrada-
tion and reorganization [25]. 
Proteases play an important 
role in this and it has been 
shown that uPA-/- mice [26] as 
well as MMP-9-/- in bone mar-
row [27], show altered arterio-
genesis in this model. uPA 
and MMP’s are produced by 
all vascular cells and in par-
ticular by infiltrating leuko-
cytes [28]. We have previously 
reported that in the wire-
induced injury of the femoral 
artery, the subsequent remod-
eling is associated with higher 
activity of MMP-2 and MMP-9 
but not uPA [9]. Since chang-
es in proteolytic activity are a 
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between the genotypes. The changes upon 
ligation within each genotype were also not sig-
nificant. Thus, the differences in arteriogenesis 
in FSAP-/- mice compared to WT mice are not 
related to changes in these proteases. 
On the other hand, gastrocnemius muscle 
showed robust changes in proteolytic activity 
associated with angiogenesis. The changes 
upon ligation within each genotype were signifi-
cant and confirm similar results from other 
reports [29]. MMP-9 and uPA activity was 
increased at day 3 in FSAP-/- mice, compared 
to WT mice, which was mirrored by increased 
protein and mRNA. MMP-2 did not follow this 
pattern. However, the increased MMP-9 and 
uPA activity in the gastrocnemius muscle of 
FSAP-/- mice may not be directly related to the 
process of angiogenesis, since capillary density 
was not different in this genotype. The use of 
whole tissue extracts may have confounded 
the results of these experiments and in situ 
zymography to measure localized changes in 
proteolytic activity may have provided more rel-
evant information that better mirror the remod-
eling changes. 
The Marburg-I, loss of function, SNP in the 
FSAP encoding gene is found in about 5% of 
Caucasians and is linked to higher odds ratio 
for carotid stenosis [5] or stroke [6]. We show 
that FSAP is capable of regulating vascular 
remodeling processes in a mouse model of 
under-expression and addition of exogenous 
FSAP. These findings consolidate the notion 
that FSAP is a vascular regulatory factor in vivo 
and that its regulation may be of therapeutic 
value.
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